Novo Financial Statements From 2010 to 2025

Novo Nordisk Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 379.7 B 361.7 B 153.1 B Slightly volatile Short and Long Term Debt Total 32.6 B 31.1 B 10.3 B Slightly volatile Total Current Liabilities 204.9 B 195.1 B 75.7 B Slightly volatile Total Stockholder Equity 128.7 B 122.5 B 62 B Slightly volatile Property Plant And Equipment Net 109.8 B 104.6 B 47 B Slightly volatile Retained Earnings 126.6 B 120.6 B 61.4 B Slightly volatile Cash 17.4 B 16.6 B 13.9 B Slightly volatile Non Current Assets Total 211.1 B 201.1 B 78.3 B Slightly volatile Cash And Short Term Investments 36.5 B 34.8 B 19.5 B Slightly volatile Net Receivables 90.9 B 86.6 B 36 B Slightly volatile Common Stock Shares Outstanding 3.7 B 4 B 3.9 B Slightly volatile Liabilities And Stockholders Equity 379.7 B 361.7 B 153.1 B Slightly volatile Non Current Liabilities Total 46.2 B 44 B 15.4 B Slightly volatile Inventory 38.4 B 36.6 B 17.9 B Slightly volatile Total Liabilities 251.1 B 239.1 B 91.1 B Slightly volatile Property Plant And Equipment Gross 167.3 B 159.4 B 61 B Slightly volatile Total Current Assets 168.6 B 160.6 B 74.8 B Slightly volatile Short Term Debt 7.8 B 7.4 B 3.2 B Slightly volatile Intangible Assets 67.5 B 64.3 B 19.9 B Slightly volatile Accounts Payable 30.9 B 29.4 B 10.2 B Slightly volatile Common Stock Total Equity 493.1 M 423 M 516.9 M Slightly volatile Common Stock 478.4 M 405.9 M 512.3 M Slightly volatile Other Liabilities 15.1 B 14.4 B 6.1 B Slightly volatile Property Plant Equipment 80.5 B 76.7 B 37.3 B Slightly volatile Current Deferred Revenue 129.9 B 123.7 B 46.6 B Slightly volatile Other Assets 16.2 B 15.4 B 6 B Slightly volatile Net Tangible Assets 37 B 36.9 B 29.1 B Slightly volatile Long Term Investments 1.5 B 1.9 B 1.3 B Slightly volatile Net Invested Capital 87.7 B 147 B 72.1 B Slightly volatile Capital Stock 374.5 M 405.9 M 469.3 M Slightly volatile
Novo Nordisk Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 11.4 B 10.8 B 3.8 B Slightly volatile Selling General Administrative 6.5 B 5.6 B 4 B Slightly volatile Total Revenue 280.5 B 267.1 B 131.9 B Slightly volatile Gross Profit 237.3 B 226 B 110.8 B Slightly volatile Other Operating Expenses 156.6 B 149.1 B 75.9 B Slightly volatile Operating Income 123.9 B 118 B 56.1 B Slightly volatile EBIT 125.5 B 119.5 B 57.1 B Slightly volatile EBITDA 136.8 B 130.3 B 60.9 B Slightly volatile Cost Of Revenue 43.2 B 41.1 B 21.2 B Slightly volatile Total Operating Expenses 113.4 B 108 B 54.7 B Slightly volatile Income Before Tax 126.4 B 120.4 B 55.4 B Slightly volatile Net Income 101 B 96.2 B 44.1 B Slightly volatile Income Tax Expense 25.3 B 24.1 B 11.3 B Slightly volatile Research Development 39.2 B 37.3 B 17.9 B Slightly volatile Net Income Applicable To Common Shares 67 B 63.9 B 33.5 B Slightly volatile Selling And Marketing Expenses 68.5 B 65.3 B 34.7 B Slightly volatile Net Income From Continuing Ops 101 B 96.2 B 39.1 B Slightly volatile Tax Provision 12.8 B 24.1 B 11.5 B Slightly volatile Interest Income 1.2 B 962.1 M 2.8 B Slightly volatile Reconciled Depreciation 6.5 B 10.8 B 5.1 B Slightly volatile
Novo Nordisk Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 84.5 B 80.5 B 39.7 B Slightly volatile Begin Period Cash Flow 8.4 B 14.6 B 12.8 B Pretty Stable Depreciation 11.4 B 10.8 B 5.1 B Slightly volatile Capital Expenditures 47 B 44.7 B 14.9 B Slightly volatile Total Cash From Operating Activities 131.5 B 125.2 B 54.6 B Slightly volatile Net Income 101 B 96.2 B 44.1 B Slightly volatile End Period Cash Flow 8.9 B 16.6 B 13.2 B Pretty Stable Dividends Paid 38.4 B 36.5 B 18.9 B Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 12.73 12.13 8.4003 Slightly volatile Dividend Yield 0.0154 0.0091 0.0173 Pretty Stable PTB Ratio 27.75 26.43 17.7898 Slightly volatile Days Sales Outstanding 64.73 106 81.7104 Slightly volatile Book Value Per Share 22.46 21.39 12.2801 Slightly volatile Free Cash Flow Yield 0.0333 0.0201 0.038 Slightly volatile Operating Cash Flow Per Share 22.96 21.87 10.8191 Slightly volatile Stock Based Compensation To Revenue 0.0087 0.0083 0.0054 Slightly volatile Capex To Depreciation 3.9 3.72 2.4339 Slightly volatile PB Ratio 27.75 26.43 17.7898 Slightly volatile EV To Sales 12.78 12.18 8.3195 Slightly volatile Free Cash Flow Per Share 14.76 14.06 7.8847 Slightly volatile ROIC 0.51 0.49 0.5347 Pretty Stable Inventory Turnover 1.71 1.29 1.2854 Pretty Stable Net Income Per Share 17.64 16.8 8.7282 Slightly volatile Days Of Inventory On Hand 214 292 289 Slightly volatile Payables Turnover 1.53 1.61 2.9857 Slightly volatile Sales General And Administrative To Revenue 0.0416 0.024 0.0357 Slightly volatile Research And Ddevelopement To Revenue 0.17 0.16 0.1392 Very volatile Capex To Revenue 0.11 0.19 0.095 Slightly volatile Cash Per Share 6.37 6.07 3.8677 Slightly volatile POCF Ratio 27.15 25.86 21.342 Slightly volatile Interest Coverage 175 125 224 Very volatile Payout Ratio 0.26 0.34 0.4059 Pretty Stable Capex To Operating Cash Flow 0.53 0.41 0.2803 Pretty Stable PFCF Ratio 42.24 40.23 29.0686 Slightly volatile Days Payables Outstanding 247 235 142 Slightly volatile Income Quality 1.44 1.5 1.2717 Very volatile ROE 0.74 0.71 0.6478 Slightly volatile EV To Operating Cash Flow 27.26 25.97 21.0954 Slightly volatile PE Ratio 35.34 33.66 25.9191 Slightly volatile Return On Tangible Assets 0.15 0.3 0.3122 Very volatile EV To Free Cash Flow 42.41 40.39 28.5686 Slightly volatile Earnings Yield 0.0292 0.0308 0.0456 Slightly volatile Intangibles To Total Assets 0.18 0.17 0.0867 Slightly volatile Current Ratio 0.9 0.95 1.3092 Slightly volatile Tangible Book Value Per Share 4.74 9.27 7.6859 Slightly volatile Receivables Turnover 5.47 3.55 4.8667 Slightly volatile Graham Number 94.43 89.93 48.969 Slightly volatile Shareholders Equity Per Share 22.46 21.39 12.2801 Slightly volatile Debt To Equity 0.18 0.29 0.1214 Slightly volatile Capex Per Share 8.2 7.81 2.9344 Slightly volatile Revenue Per Share 48.96 46.63 26.1091 Slightly volatile Interest Debt Per Share 5.85 5.57 2.2577 Slightly volatile Debt To Assets 0.1 0.0988 0.0508 Slightly volatile Enterprise Value Over EBITDA 26.2 24.95 18.5497 Slightly volatile Short Term Coverage Ratios 25.52 18.48 58.7743 Very volatile Price Earnings Ratio 35.34 33.66 25.9191 Slightly volatile Operating Cycle 279 399 371 Slightly volatile Price Book Value Ratio 27.75 26.43 17.7898 Slightly volatile Days Of Payables Outstanding 247 235 142 Slightly volatile Dividend Payout Ratio 0.26 0.34 0.4059 Pretty Stable Price To Operating Cash Flows Ratio 27.15 25.86 21.342 Slightly volatile Price To Free Cash Flows Ratio 42.24 40.23 29.0686 Slightly volatile Pretax Profit Margin 0.22 0.41 0.3794 Pretty Stable Ebt Per Ebit 1.88 1.17 1.0983 Very volatile Operating Profit Margin 0.42 0.4 0.394 Slightly volatile Effective Tax Rate 0.3 0.23 0.2212 Pretty Stable Company Equity Multiplier 1.41 2.66 2.1148 Slightly volatile Long Term Debt To Capitalization 0.11 0.15 0.1209 Slightly volatile Total Debt To Capitalization 0.14 0.23 0.0976 Slightly volatile Return On Capital Employed 0.67 0.64 0.6979 Pretty Stable Debt Equity Ratio 0.18 0.29 0.1214 Slightly volatile Ebit Per Revenue 0.42 0.4 0.394 Slightly volatile Quick Ratio 0.69 0.73 0.9807 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.33 1.39 1.6749 Slightly volatile Net Income Per E B T 0.58 0.72 0.7682 Pretty Stable Cash Ratio 0.0927 0.0976 0.362 Slightly volatile Cash Conversion Cycle 206 163 243 Pretty Stable Operating Cash Flow Sales Ratio 0.22 0.42 0.3592 Slightly volatile Days Of Inventory Outstanding 214 292 289 Slightly volatile Days Of Sales Outstanding 64.73 106 81.7104 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.42 0.58 0.7159 Pretty Stable Cash Flow Coverage Ratios 3.45 3.63 38.9983 Slightly volatile Price To Book Ratio 27.75 26.43 17.7898 Slightly volatile Fixed Asset Turnover 1.71 2.3 2.8947 Slightly volatile Capital Expenditure Coverage Ratio 2.74 2.52 4.7382 Slightly volatile Price Cash Flow Ratio 27.15 25.86 21.342 Slightly volatile Enterprise Value Multiple 26.2 24.95 18.5497 Slightly volatile Debt Ratio 0.1 0.0988 0.0508 Slightly volatile Cash Flow To Debt Ratio 3.45 3.63 38.9983 Slightly volatile Price Sales Ratio 12.73 12.13 8.4003 Slightly volatile Return On Assets 0.14 0.24 0.2867 Pretty Stable Asset Turnover 0.66 0.7385 0.9316 Slightly volatile Net Profit Margin 0.34 0.32 0.3095 Slightly volatile Gross Profit Margin 0.58 0.76 0.7947 Very volatile Price Fair Value 27.75 26.43 17.7898 Slightly volatile Return On Equity 0.74 0.71 0.6478 Slightly volatile
Novo Nordisk Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 781.9 B 744.7 B 701.7 B Slightly volatile Enterprise Value 765.7 B 729.2 B 687.1 B Slightly volatile

Novo Fundamental Market Drivers

Novo Upcoming Events

About Novo Nordisk Financial Statements

Pair Trading with Novo Nordisk

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novo Nordisk position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will appreciate offsetting losses from the drop in the long position's value.When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:

How To Invest In Novo Details

Is Novo Stock a good investment? Details

What is Novo Nordisk's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details